Article
Current views on the genetic landscape and management of variant acute promyelocytic leukemia
6 May 2021
Abstract excerpt
Acute promyelocytic leukemia (APL) is characterized by the accumulation of promyelocytes in bone marrow. More than 95% of patients with this disease belong to typical APL, which express PML-RARA and are sensitive to differentiation induction therapy containing all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), and they exhibit an excellent clinical outcome. Compared to typical APL, variant APL showed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
